Compare CTMX & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTMX | USEG |
|---|---|---|
| Founded | 2008 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 39.1M |
| IPO Year | 2015 | N/A |
| Metric | CTMX | USEG |
|---|---|---|
| Price | $4.25 | $0.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $6.50 | $3.50 |
| AVG Volume (30 Days) | ★ 2.8M | 404.6K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.22 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $113,631,000.00 | $9,484,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $57.52 |
| P/E Ratio | $17.36 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.40 | $0.92 |
| 52 Week High | $4.62 | $6.40 |
| Indicator | CTMX | USEG |
|---|---|---|
| Relative Strength Index (RSI) | 56.24 | 42.18 |
| Support Level | $4.07 | $0.93 |
| Resistance Level | $4.48 | $1.03 |
| Average True Range (ATR) | 0.26 | 0.06 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 65.60 | 10.87 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.